Optimal Management of Diabetic Retinopathy: Leveraging the Treatment Evidence - Final Assessment

Launch Date:
December 09, 2022
Return to Enrollment Page

Primary Audience:

Retina specialists, retina fellows, and select comprehensive ophthalmologists

Relevant Terms:

Diabetes, Nonproliferative diabetic retinopathy, Proliferative diabetic retinopathy, Center-involved diabetic retinopathy, Anti-vascular endothelial growth factor

LEARNING OBJECTIVES

1.
Assess the effects of intravitreal anti-VEGF therapy on DR/DME, as evidenced by recent data
2.
Differentiate among new and emerging strategies for more durable dosing of anti-VEGF to treat DR/DME
3.
Develop treatment plans for patients with DR/DME that are safe, effective, and tailored to patients’ clinical needs and personal preferences